4.5 Review

Imminent fracture risk

期刊

OSTEOPOROSIS INTERNATIONAL
卷 28, 期 6, 页码 1765-1769

出版社

SPRINGER LONDON LTD
DOI: 10.1007/s00198-017-3976-5

关键词

Fracture; Imminent; Osteoporosis; Treatment

资金

  1. Alexion
  2. Amgen
  3. Lilly
  4. UCB
  5. MSD
  6. PFIZER

向作者/读者索取更多资源

The clinical significance of osteoporosis is in the occurrence of fractures and re-fractures. The main risk factor of sustaining a fracture is a previous one, but a recent fracture is a better fracture risk factor than fracture history. The role of the recency of fracture has been shown for both vertebral and non-vertebral fracture risk. This imminent risk is explained by both bone-related factors (underlying osteoporosis) and fall-related factors (including those related to postfracture care). Such a short-term increased risk has been shown also in patients initiating corticosteroids and in frail osteoporotic subjects with central nervous system (CNS) diseases or drugs targeting CNS, and thus a high risk of falls. Patients with an imminent (i.e. 2 years) risk of fracture or refracture should be identified in priority in order to receive an immediate treatment and a program of fall prevention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据